NCT02213081View on ClinicalTrials.gov

Ulipristal for Endometriosis-related Pelvic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions
Endometriosis
Interventions
DRUG

Ulipristal

Patient will take 15mg every other day, or every 4 days per week.

Trial Locations (1)

60611

Northwestern University, Prentice Women's Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT02213081 - Ulipristal for Endometriosis-related Pelvic Pain | Biotech Hunter | Biotech Hunter